Life science Reports

CBD oil is a plant-based extract obtained from cannabis, predominantly sourced from industrial hemp strains that contain very low levels of THC. The extract is commonly blended with carrier oils such as hemp seed oil or coconut oil to enhance bioavailability. Available in various formulations including full-spectrum CBD, which preserves multiple cannabinoids and terpenes, and CBD isolate, offering pure cannabidiol CBD oil has become a widely used ingredient across health, wellness, and personal care industries. CBD Oil Market Size and Growth The  CBD oil market  is set to witness remarkable growth over the coming years, supported by favorable regulatory shifts, expanding product awareness, and rising demand for natural wellness solutions. The market was valued at  US$ 5.80 billion in 2024  and is expected to reach  US$ 15.66 billion by 2031 , growing at an impressive  CAGR of 31.2% during the 2025–2031 forecast period . This growth reflects increasing ...

Heart tumors, also known as cardiac tumors, are rare growths that can be classified as primary (originating in the heart) or secondary (metastatic from other organs). Primary heart tumors are extremely uncommon, occurring in fewer than 1 in 5,000 individuals, and are largely benign, accounting for 75-90% of cases. Myxomas are the most prevalent type of primary heart tumor, typically arising in the atria, and can lead to obstruction, embolism, or arrhythmias. Heart Tumor Market Outlook and Forecast The  global Heart Tumor Market  is expected to grow substantially from 2025 to 2031, achieving a  CAGR of 8.0% . This growth is driven by the increasing prevalence of cardiac tumors, heightened patient awareness regarding early diagnosis and treatment, and rapid advancements in medical technologies. The report by The Insight Partners provides a comprehensive analysis of market trends, competitive dynamics, and growth opportunities, segmented by tumor type, diagnostic methods, tr...

  The   Arthroscopy Devices Market   is experiencing sustained growth as minimally invasive orthopedic procedures gain widespread acceptance across hospitals, ambulatory surgical centers, and specialty orthopedic clinics.   The market size was valued at US$ 7.84 billion in 2025 and is expected to reach US$ 15.90 billion by 2034,   reflecting strong expansion supported by technological innovation, increasing procedure volumes, and broader access to advanced surgical care. Arthroscopy devices are specialized medical tools used to diagnose and treat joint-related disorders through minimally invasive techniques. These devices allow surgeons to visualize joint interiors and perform complex reparative procedures with smaller incisions, reduced tissue trauma, and faster patient recovery compared to traditional open surgeries. Market Analysis: Impact of Rising Sports Injuries One of the most significant factors reshaping the Arthroscopy Devices Industry is the rising in...

Orthopedic orthotics are specialized medical devices designed to assist in the correction, support, and alignment of the musculoskeletal system. These devices, which include braces, splints, insoles, and spinal supports, are either prefabricated or customized to meet individual patient needs. Orthotic solutions are widely used to reduce pain, improve mobility, and prevent further injury in patients suffering from orthopedic conditions such as joint degeneration, trauma, congenital deformities, and post-operative complications. Global Orthopedic Orthotics Market Snapshot The  global   Orthopedic Orthotics Market  is experiencing sustained growth due to increasing orthopedic disorders and technological improvements in device manufacturing. According to The Insight Partners, the market is forecasted to reach  US$ 7.17 billion by 2031 , expanding at a  CAGR of 5.9% between 2025 and 2031 . Rising healthcare expenditure and greater focus on early diagnosis and correct...

The metabolomics services market is experiencing rapid expansion as life science industries increasingly rely on advanced molecular profiling to gain actionable biological insights. The Metabolomics Services Industry size is expected to reach US$ 6.92 Billion by 2034 from US$ 1.12 Billion in 2025. The market is anticipated to register a CAGR of 22.39% during 2026–2034. This strong growth trajectory reflects the rising adoption of metabolomics across pharmaceutical research, agritech innovation, and environmental monitoring, where precise small molecule analysis is essential for decision making and regulatory compliance.   Metabolomics Services Market Overview Metabolomics services focus on the qualitative and quantitative analysis of metabolites present in biological samples. These services are delivered by specialized contract research organizations, academic core facilities, and technology driven service providers. Using advanced platforms such as liquid chromatography m...

The global   drug delivery market   is witnessing a period of rapid growth, driven by increasing prevalence of chronic diseases, technological innovation, and rising demand for targeted and patient-friendly therapies. Market Size ,Share And Trends According To The Insight Partners, The  drug delivery market valued at US$ 2,247.26 billion in 2023, is projected to reach US$ 4,228.64 billion by 2031, registering a robust CAGR of 8.7% during the forecast period . Innovations in drug delivery systems, such as non-invasive platforms, nanotechnology-based solutions, and smart injectable devices, are revolutionizing therapeutic approaches and improving patient outcomes worldwide. Rising Demand for Targeted and Non-Invasive Therapies Chronic diseases, including diabetes, cancer, cardiovascular disorders, neurological conditions, and respiratory illnesses, are major drivers of the drug delivery market. These conditions require precise and long-term therapeutic management, which has...

Pharmaceutical grade sorbitol is a high-purity sugar alcohol (C6H14O6, CAS 50-70-4) derived from glucose, appearing as a white, crystalline powder or colorless mass with a sweet taste, highly soluble in water and slightly in alcohol, and meeting stringent purity standards of at least 98-101% on a dry basis. The  Pharmaceutical Grade Sorbitol Market  is projected to experience steady growth from 2026 to 2034, driven by rising applications in pharmaceuticals, nutraceuticals, and personal care products. Sorbitol, a high-purity sugar alcohol, is widely used as a sweetener, humectant, and bulking agent. It plays a critical role in tablet formulations, laxatives, antacids, and cosmetic products. Increasing consumer demand for sugar alternatives, coupled with advancements in sustainable production methods, is fueling market growth across the globe. The market is also benefiting from innovations in drug delivery systems and personalized medicine. Pharmaceutical manufacturers are lever...

  The   patient-derived xenograft model   market refers to the global industry focused on developing and supplying PDX models, where tumor tissues taken directly from cancer patients are implanted into immunodeficient animals such as mice and rats. These models preserve tumor heterogeneity and clinically relevant genetic features, which makes them valuable for oncology drug discovery, translational research, and biomarker validation.   The patient-derived xenograft model market is projected to grow from US$ 468.75 million in 2024 to US$ 1,119.36 million by 2031. The market is expected to register a CAGR of 13.5% during 2025 to 2031.   Competitive intensity is increasing as sponsors demand faster timelines, deeper multi-omics integration, and broader tumor model availability across major solid tumor and hematological indications. Sample PDF:-   https://www.theinsightpartners.com/sample/TIPRE00021693 Market Context and Competitive Landscape The competitive la...

  The   CRISPR and Cas Gene Market   encompasses technologies, products, and services that utilize CRISPR sequences and Cas enzymes to enable precise and efficient genome editing. These tools are widely used for modifying DNA and RNA in research laboratories, therapeutic development, and biotechnology applications. The CRISPR and Cas Gene Market is gaining global recognition due to its ability to deliver accurate gene modifications with reduced cost and shorter development timelines. Increasing adoption across academic research, pharmaceutical development, and biotechnology manufacturing continues to strengthen the market foundation. Market Overview and Revenue Forecast The global CRISPR and Cas Gene Industry is witnessing strong revenue expansion during the period from 2024 to 2031. The market size was valued at US$ 4.13 billion in 2024 and is projected to reach US$ 18.04 billion by 2031. The market is expected to register a CAGR of 23.4% during the forecast period from ...